These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 11575176)
1. [New quinolones, current therapies]. Auckenthaler R Schweiz Rundsch Med Prax; 1988 Nov; 77(45):1217-8. PubMed ID: 2847274 [No Abstract] [Full Text] [Related]
2. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist]. Schurz JK Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176 [No Abstract] [Full Text] [Related]
4. [How well do gyrase inhibitors work? The pharmacokinetics of quinolones]. Sörgel F; Bulitta J; Kinzig-Schippers M Pharm Unserer Zeit; 2001; 30(5):418-27. PubMed ID: 11575179 [No Abstract] [Full Text] [Related]
5. [Quinolones in the environment: biological breakdown of gyrase inhibitors]. Wetzstein HG Pharm Unserer Zeit; 2001; 30(5):450-7. PubMed ID: 11575183 [No Abstract] [Full Text] [Related]
6. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]. Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686 [No Abstract] [Full Text] [Related]
7. Molecular mechanisms of drug inhibition of DNA gyrase. Lewis RJ; Tsai FT; Wigley DB Bioessays; 1996 Aug; 18(8):661-71. PubMed ID: 8760340 [TBL] [Abstract][Full Text] [Related]
8. New generations of quinolones: with particular attention to levofloxacin. Ambrose PG; Owens RC; Quintiliani R; Nightingale CH Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076 [No Abstract] [Full Text] [Related]